LEADER 01445nam  2200469   450 
001 9910151731903321
005 20230803015507.0
010   $a1-62618-759-2
035   $a(CKB)3710000000952247
035   $a(MiAaPQ)EBC4759661
035   $a(EXLCZ)993710000000952247
100   $a20161221h20132013  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aPharmaceutical patents $eissues and considerations /$fFlorian Aerts, editor
210  1$aNew York :$cNovinka,$d[2013]
210  4$dİ2013
215   $a1 online resource (104 pages)
225 1 $aLaws and legislation
311   $a1-62618-758-4 
320   $aIncludes bibliographical references and index.
410  0$aLaws and legislation series.
606   $aPatent laws and legislation$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aPharmacy$xLaw and legislation$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
615  0$aPatent laws and legislation
615  0$aPharmaceutical industry
615  0$aPharmacy$xLaw and legislation
615  0$aDrugs$xLaw and legislation
676   $a615.1
702   $aAerts$b Florian
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910151731903321
996   $aPharmaceutical patents$93409931
997   $aUNINA